Top

Abdominal Radiology

Published in:

01-05-2022 | Ultrasound | Kidneys, Ureters, Bladder, Retroperitoneum

Value of contrast-enhanced ultrasound for diagnosis and follow-up of renal artery stenosis in patients with chronic kidney disease

Authors: Tianhui Li, Yonghui Mao, Ban Zhao, Haitao Wang, Junhong Ren, Na Ma, Siyu Wang

Published in: Abdominal Radiology | Issue 5/2022

Abstract

Objective

To evaluate whether contrast-enhanced ultrasound (CEUS) is an accurate, non-nephrotoxic diagnostic method and follow-up tool for use in patients with chronic kidney disease (CKD) and renal artery stenosis (RAS).

Methods

In this prospective and monocentric study, we compared the sensitivity and specificity of CEUS for the diagnosis of RAS in CKD patients, using digital subtraction angiography (DSA) or computed tomographic angiography (CTA) as the gold standard methods. Further, the value of CEUS for distinguishing restenosis from other diseases was assessed. The ultrasound physicians conducted the examinations and served as the CEUS report readers who were blinded to the DSA or CTA results.

Results

Patients with RAS (n = 60) were enrolled. Average patient age was 64.4 ± 18.0 years and median estimated glomerular filtration rate was 66.1 mL/min/1.73 m². CEUS was used to image 94 stenotic renal arteries and DSA- or CTA-verified stenosis was present in 96 renal arteries. The kappa value for CEUS was 0.776 (P < 0.001), with an accuracy of 92.5%, a sensitivity of 94.7%, and a specificity of 84.0%. The accuracy of CEUS was the same for the diagnosis of the CKD3b–5 group as for the CKD1–3a group (100% vs. 87.5%, P = 0.148). There was no difference in CEUS accuracy for the diagnosis of Takayasu RAS compared with atherosclerotic RAS (95.8% vs. 91.7%, P = 0.795). Twenty-nine CEUS examinations were performed to follow in-stent restenosis or progression of RAS, with a median follow-up time of 5.0 months (range 1.0–20.0). Two cases of in-stent restenosis in patients suffering from deteriorating kidney function and recurrent hypertension were examined by CEUS.

Conclusion

CEUS examination is a credible alternative for diagnosing moderate and severe RAS in patients with CKD, and is a reliable tool for follow-up surveillance after renal artery revascularization treatment. It shouldn’t be thought as a color-coded duplex ultrasonography rescue in these patients.

Khatami MR (2013) Ischemic nephropathy: more than a simple renal artery narrowing. Iran J Kidney Dis 7:82–100.PubMed

Kennedy DJ, Colyer WR, Brewster PS, et al (2003) Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis 42(5):926–935. doi: https://doi.org/10.1016/j.ajkd.2003.06.004.CrossRefPubMed

Gupta R, Syed M, Ashcherkin N, et al (2019) Renal Artery Stenosis and Congestive Heart Failure: What Do We Really Know. Curr Cardiol Rep 21:74. doi: https://doi.org/10.1007/s11886-019-1169-x.CrossRefPubMed

Rountas C, Vlychou M, Vassiou K, et al (2007) Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital subtraction angiography. Ren Fail 29(3):295–302. doi: https://doi.org/10.1080/08860220601166305.CrossRefPubMed

Kim TS, Chung JW, Park JH, et al (1998) Renal artery evaluation: comparison of spiral CT angiography to intra-arterial DSA. J Vasc Interv Radiol 9(4):553–559. doi: https://doi.org/10.1016/s1051-0443(98)70320-3CrossRefPubMed

Beregi JP, Louvegny S, Ceugnart L, et al (1997) Helical X-ray computed tomography of renal arteries. Apropos of 300 patients. J Radiol 78(8):549–556.

Davenport MS, Perazella MA, Yee J, et al (2020) Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology 294(3):660–668. doi:https://doi.org/10.1148/radiol.2019192094.CrossRefPubMed

Rowe AS, Hawkins B, Hamilton LA, et al (2019) Contrast-Induced Nephropathy in Ischemic Stroke Patients Undergoing Computed Tomography Angiography: CINISter Study. J Stroke Cerebrovasc Dis 28(3):649–654. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.11.012.CrossRefPubMed

Piskinpasa S, Altun B, Akoglu H, et al (2013) An uninvestigated risk factor for contrast-induced nephropathy in chronic kidney disease: proteinuria. Ren Fail 35(1):62–65. doi: https://doi.org/10.3109/0886022X.2012.741646.CrossRefPubMed

10.

Piscaglia F, Nolsøe C, Dietrich CF, et al (2012) The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59. doi: https://doi.org/10.1055/s-0031-1281676.CrossRefPubMed

11.

Clevert DA, Horng A, Clevert DA, et al (2009) Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection. Clin Hemorheol Microcirc 43:129–139. doi: https://doi.org/10.3233/CH-2009-1227.CrossRefPubMed

12.

Ren JH, Ma N, Wang SY, et al (2018) Clinical value of contrast-enhanced sonography for elderly with renal artery stenosis. Chin J Geriatr March 37(3):276–279.

13.

Pan FS, Liu M, Luo J, et al (2017) Transplant renal artery stenosis: Evaluation with contrast-enhanced ultrasound. Eur J Radiol 90:42–49. doi: https://doi.org/10.1016/j.ejrad.2017.02.031.CrossRefPubMed

14.

Adani GL, Como G, Bonato F, et al (2018) Detection of transplant renal artery stenosis with contrast-enhanced ultrasound. Radiol Case Rep 13(3):890–894. doi: https://doi.org/10.1016/j.radcr.2018.06.003.CrossRefPubMedPubMedCentral

15.

Palevsky PM, Liu KD, Brophy PD, et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61(5):649–672. doi: https://doi.org/10.1053/j.ajkd.2013.02.349.CrossRefPubMed

16.

Schäberle W, Leyerer L, Schierling W, et al (2016) Ultrasound diagnostics of renal artery stenosis: Stenosis criteria, CEUS and recurrent in-stent stenosis. Gefasschirurgie 21:4–13. doi: https://doi.org/10.1007/s00772-015-0060-3.CrossRefPubMed

17.

Ren JH (2020) Standardized thought of examination and operation with contrast-enhanced ultrasound for diagnosis of renal artery stenosis. Zhonghua Yi Xue Za Zhi 100(17):1281–1283.CrossRefPubMed

18.

He Wen, Ren JH, Ma N, et al (2021) Chinese expert consensus on methods and procedures of renal artery contrast-enhanced ultrasound 2021 Edition. Chin J Ultrasonogr 30(11):921–925.

19.

Bokor D, Chambers JB, Rees PJ, et al (2001) Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 36(2):104–109. doi: https://doi.org/10.1097/00004424-200102000-00006.CrossRefPubMed

20.

Claudon M, Plouin PF, Baxter GM, et al (2000) Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group. Radiology 214(3):739–746. doi: https://doi.org/10.1148/radiology.214.3.r00fe02739.

21.

Cui Y, Zhang Q, Yan J, et al (2020) The Value of Contrast-Enhanced Ultrasound versus Doppler Ultrasound in Grading Renal Artery Stenosis. Biomed Res Int 2020:7145728. doi: https://doi.org/10.1155/2020/7145728.CrossRefPubMedPubMedCentral

22.

Martinoli C, Derchi LE, Rizzatto G, et al (1998) Power Doppler sonography: general principles, clinical applications, and future prospects. Eur Radiol 8(7):1224–1235. doi: https://doi.org/10.1007/s003300050540.CrossRefPubMed

23.

Mueller-Peltzer K, Rübenthaler J, Fischereder M, et al (2017) The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities. Clin Hemorheol Microcirc 67(3–4):407–413. doi: https://doi.org/10.3233/CH-17922.CrossRefPubMed

24.

Ren JH, Ma N, Wang SY, et al (2019) Diagnostic value of contrast-enhanced sonography and digital subtraction angiography for renal artery stenosis. Zhonghua Yi Xue Za Zhi 99(3):209–211.CrossRefPubMed

25.

Xu X, Lin X, Huang J, et al (2017) The capability of inflow inversion recovery magnetic resonance compared to contrast-enhanced magnetic resonance in renal artery angiography. Abdom Radiol (NY) 42(10):2479–2487. doi: https://doi.org/10.1007/s00261-017-1161-0.CrossRef

26.

Ritchie J, Green D, Chrysochou C, et al (2014) High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis 63(2):186–197. doi: https://doi.org/10.1053/j.ajkd.2013.07.020.CrossRefPubMed

27.

Takahashi EA, McKusick MA, Bjarnason H, et al (2016) Treatment of In-Stent Restenosis in Patients with Renal Artery Stenosis. J Vasc Interv Radiol 27(11):1657–1662. doi: https://doi.org/10.1016/j.jvir.2016.05.041.CrossRefPubMed

28.

Bax L, Mali WP, Van De Ven PJ, et al (2002) Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 13(12):1219–1224. doi: https://doi.org/10.1016/s1051-0443(07)61968-x.CrossRefPubMed

29.

Drelich-Zbroja A, Jargiello T, Drelich G, et al (2004) Renal artery stenosis: value of contrast-enhanced ultrasonography. Abdom Imaging 29(4):518–524. doi: https://doi.org/10.1007/s00261-003-0125-8.CrossRefPubMed

Title: Value of contrast-enhanced ultrasound for diagnosis and follow-up of renal artery stenosis in patients with chronic kidney disease
Authors: Tianhui Li
Yonghui Mao
Ban Zhao
Haitao Wang
Junhong Ren
Na Ma
Siyu Wang
Publication date: 01-05-2022
Publisher: Springer US
Keywords: Ultrasound
Renal Artery Stenosis
Angiography
Renal Artery Stenosis
Ultrasound
Chronic Kidney Disease
Published in: Abdominal Radiology / Issue 5/2022
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-022-03457-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2022

Is rectal filling optimal for MRI-based radiomics in preoperative T staging of rectal cancer?

Introduction to the special issue on intestinal ischemia

Non-occlusive mesenteric ischemia (NOMI) and prognostic signs at CT: reperfusion or not reperfusion that is the question!

Predictors of biliary intervention in patients hospitalized for COVID-19

Computed-tomography angiography in arterial acute intestinal ischemia: prognostic interest of vascular semiology

Mesenteric ischemia: a radiologic perspective

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials